drugset / Trial / NCT07209475
Effect of Amnio-Maxx on the Healing Rate of Chronic Diabetic Foot Ulcers.
RandomizedParallel-groupOpen-labelTreatment
Summary
This study will evaluate a cellular, acellular, matrix-like product (CAMP) and Standard of Care (SOC) versus SOC alone in the closure of nonhealing diabetic foot ulcers (DFUs). The study will evaluate Amnio-Maxx® Dual Layer Amnion Patch.
Timeline
- Start
- 2025-08-14
- Primary completion
- 2026-08-14
- Completion
- 2026-08-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amnio-Maxx® Dual Layer Amnion Patch | Unknown | — | Other |